Fig. 4From: Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinomaHCC subtype validation in ICGC-HCC dataset. A, B Prognostic effects of SVM-based HCC subtype on HCC OS. C, D Prognostic effects of NTP-based HCC subtype on HCC OS. F, G Comparisons of LSGs score, stemness score, and aging score in different ICGC-HCC subtypes. H–J Comparisons of LSGs score, stemness score, and aging score in different ICGC-HCC subtypes. K–M Comparisons of immune score, stromal score, and estimate score (tumor purity) in different ICGC-HCC subtypesBack to article page